Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.26 (
GSK
)
6,788
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Communication between mammalian oocytes and their surrounding granulosa cells through the Kit-Kit ligand (KL, or
stem cell factor, SCF
) system has been shown to be crucial for follicular development. Our previous studies (Reddy et al. 2005, Liu et al. 2006) have indicated that the intra-oocyte KL-Kit-PI3 kinase (PI3K)-Akt-Foxo3a cascade may play an important role in follicular activation and early development. In the present study, using in situ hybridization and in vitro culture of growing oocytes from 8-day-old postnatal mice, we have demonstrated that another Akt substrate, glycogen synthase kinase-3 (GSK-3), is expressed in growing oocytes. Also, treatment of cultured mouse oocytes with soluble KL not only leads to increased Akt kinase activity in the oocytes, which can phosphorylate recombinant
GSK
-3 in vitro, but also leads to phosphorylation of oocyte
GSK
-3alpha and
GSK
-3beta, which can result in the inactivation of
GSK
-3 function in oocytes. In addition, we have shown that the regulation of
GSK
-3alpha and
GSK
-3beta in cultured oocytes by soluble KL is accomplished through PI3K, since the PI3K-specific inhibitor LY294002 completely abolished the KL-induced phosphorylation of
GSK
-3alpha and
GSK
-3beta. Moreover, blockage of the Kit signaling pathway by a Kit function-blocking antibody, ACK2, resulted in reduced phosphorylation of
GSK
-3. Taken together, our data suggest that the cascade from granulosa cell-derived KL to Kit-PI3K-Akt-
GSK
-3 in oocytes may take part in regulation of oocyte growth and early ovarian follicular development.
...
PMID:Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development. 1724 76